The Global Oligonucleotide API Industry is poised for significant expansion, driven by the rising demand for novel drug classes. According to a recent market analysis, the market, currently valued at US$2.81 billion in 2024, is expected to climb steadily at a Compound Annual Growth Rate (CAGR) of 5.60% over the next decade. This positive growth …
Tag Archives: Global Oligonucleotide API Market
Global Oligonucleotide API Industry Eyes a Striking US$ 4.84 Billion Expansion, Riding the Wave of a 5.60% CAGR through 2034 | FMI
In response to the escalating demand for innovative drug classes, the Global Oligonucleotide API Industry is poised for a remarkable surge, with a projected high Compound Annual Growth Rate (CAGR) of 5.60% from 2024 to 2034. According to market analysts, this surge is expected to propel the global oligonucleotide API market from its 2024 valuation …
Global Oligonucleotide API Industry Soars with a Projected 10.2% CAGR, Anticipating a US$5.36 Billion Market by 2030 | Reveals FMI Analysis
The Global Oligonucleotide API Industry is poised for a transformative journey, with a forecasted Compound Annual Growth Rate (CAGR) of 10.2% from 2022 to 2030. Fueled by escalating demand for innovative drug classes, this sector emerges as a beacon of promise within the pharmaceutical industry. In a groundbreaking analysis by Future Market Insights (FMI), the …
Global Oligonucleotide API Industry Poised for a Remarkable US$ 5.36 Billion Growth, Fueled by a Steady 10.2% CAGR till 2030 | FMI
The Global Oligonucleotide API Market is poised for substantial growth between 2022 and 2030, with a robust CAGR of 10.2%, primarily driven by the increasing demand for innovative drug classes. Consequently, it is projected that by the close of 2030, the global market for oligonucleotide Active Pharmaceutical Ingredients (APIs) will have surged from a valuation of US$ …
Global Oligonucleotide API Industry’s Remarkable CAGR of 10.2% Leading to a US$5.36 Billion Market in 2030 | FMI Reports
The Global Oligonucleotide (API) Industry is on the verge of a remarkable transformation, with a forecasted Compound Annual Growth Rate (CAGR) of 10.2% between 2022 and 2030. This substantial growth is fueled by the surging demand for innovative drug classes, making it one of the most promising sectors in the pharmaceutical industry. According to a …